A Multicenter Patient Registry for Outcomes of Inappropriate Sinus Tachycardia and Postural Orthostatic Tachycardia Syndrome Treatment
Status: Recruiting
Location: See all (15) locations...
Intervention Type: Device
Study Type: Observational
SUMMARY
The primary objective of this registry is to capture real-world safety and performance data on AtriCure devices used to ablate cardiac tissue when treating Inappropriate Sinus Tachycardia (IST) or Postural Tachycardia Syndrome (POTS). This is a retrospective and prospective, multicenter, US/OUS, observational data registry.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 100
Healthy Volunteers: f
View:
• Subject is scheduled to undergo or has undergone a procedure to treat IST or POTS using one or more AtriCure devices.
• Subject is willing to provide written informed consent (defined as legally effective, documented confirmation of a subject's voluntary agreement to participate in this Registry) or authorization per institution and geographical requirements
Locations
United States
California
Loma Linda University Health
RECRUITING
Loma Linda
Stanford University
RECRUITING
Palo Alto
Sequoia Hospital
RECRUITING
Redwood City
Florida
University of Florida
RECRUITING
Gainesville
HCA Osceola Regional Medical Center
RECRUITING
Kissimmee
Sarasota Memorial Hospital
RECRUITING
Sarasota
Kansas
Kansas City Cardiac Arrhythmia Research
RECRUITING
Kansas City
Maryland
MedStar Health Research Institute
RECRUITING
Hyattsville
Ohio
The Carl & Edyth Lindner Center for Research & Education at The Christ Hospital
RECRUITING
Cincinnati
Texas
Texas Cardiac Arrhythmia Research Foundation
RECRUITING
Austin
Utah
Intermountain Medical Center
RECRUITING
Murray
Washington
Swedish Health Services
RECRUITING
Seattle
Other Locations
Belgium
Universitair Ziekenhuis Brussels
RECRUITING
Brussels
Italy
IRCCS Ospedale San Raffaele
RECRUITING
San Raffaele
Poland
Central Clinic Hospital
RECRUITING
Warsaw
Contact Information
Primary
Registry Specialist
IST-Registry@atricure.com
866-349-2342
Time Frame
Start Date: 2022-03-01
Estimated Completion Date: 2027-01
Participants
Target number of participants: 500
Related Therapeutic Areas
Sponsors
Leads: AtriCure, Inc.